Free Trial
Notice: Trading of Ikena Oncology halted at 08:25 AM EST due to "News pending".

Ikena Oncology (IKNA) Earnings Date, Estimates & Call Transcripts

Ikena Oncology logo
$1.67 +0.12 (+7.74%)
(As of 05:45 PM ET)

Ikena Oncology Latest Earnings Summary

Actual EPS
(Nov. 7)
-$0.19 Beat By $0.08
Consensus EPS
(Nov. 7)
-$0.27

Ikena Oncology issued Q3 2024 earnings on November 7, 2024, reporting an EPS of -$0.19, which beat the consensus estimate of -$0.27 by $0.08. With a trailing EPS of -$1.23, Ikena Oncology's earnings are expected to grow next year, from ($0.91) to ($0.70) per share.

Get Ikena Oncology Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ikena Oncology and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

IKNA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IKNA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ikena Oncology Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$0.44-$0.42-$0.43
Q2 20243-$0.37-$0.27-$0.31
Q3 20243-$0.32-$0.19-$0.26
Q4 20243-$0.25-$0.17-$0.21
FY 202411-$1.38-$1.05-$1.20
Q1 20252-$0.20-$0.18-$0.19
Q2 20252-$0.20-$0.15-$0.18
Q3 20252-$0.20-$0.14-$0.17
Q4 20252-$0.20-$0.14-$0.17
FY 20258($0.80)($0.61)($0.71)

Ikena Oncology Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/7/2024Q3 2024-$0.27-$0.19+$0.08-$0.17--
8/8/2024Q2 2024-$0.31-$0.27+$0.04-$0.26--
5/13/2024Q1 2024-$0.40-$0.28+$0.12-$0.23--
3/12/2024Q4 2023-$0.41-$0.41--$0.41$2.39M$0.66M
11/9/2023Q3 2023-$0.44-$0.40+$0.04-$0.40--
8/10/2023Q2 2023-$0.48-$0.44+$0.04-$0.44$3.63M$2.00M
5/15/2023Q1 2023-$0.46-$0.39+$0.07-$0.39$4.91M$5.31M
3/14/2023Q4 2022-$0.53-$0.39+$0.14-$0.39$3.26M$5.45M

Ikena Oncology Earnings - Frequently Asked Questions

Ikena Oncology (NASDAQ:IKNA) last announced its quarterly earning data on Thursday, November 7, 2024. Learn more on IKNA's earnings history.

In the previous quarter, Ikena Oncology (NASDAQ:IKNA) reported ($0.19) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.27) by $0.08. Learn more on analysts' earnings estimate vs. IKNA's actual earnings.

Ikena Oncology (NASDAQ:IKNA) has a recorded annual revenue of $659,000.00.

Ikena Oncology (NASDAQ:IKNA) has a recorded net income of -$68.17 million. IKNA has generated -$1.23 earnings per share over the last four quarters.

Ikena Oncology's earnings are expected to grow from ($0.91) per share to ($0.70) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:IKNA) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners